ریتوکسیامب در میاستنی گراویس کلیوی: تجزیه و تحلیل ویژگی های بالینی، کیفیت زندگی و هزینه

Rituximab is a clinical effective treatment for B cell-related diseases like MG and seems to be a cost–saving intervention. Its use is associated with a decrease in the need for other immunosuppressive treatments whilst improving quality of life and reducing health costs.